Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2014 06:15 ET | Source: uniQure

uniQure Announces Will Lewis as New Board Member

AMSTERDAM, Netherlands, June 12, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that Will Lewis has joined uniQure's Supervisory Board as of June...
June 06, 2014 05:11 ET | Source: uniQure

uniQure Announces Results for the First Quarter 2014

--Platform Positioned to Develop the Next Generation of Novel Gene Therapies-- AMSTERDAM, The Netherlands, June 6, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene...
June 03, 2014 11:13 ET | Source: uniQure

uniQure Announces Analysis of Six-Year Follow-up Data for Glybera(R)

--50% Fewer Pancreatitis Events, No Severe Pancreatitis Post One-time Treatment-- AMSTERDAM, The Netherlands, June 3, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene...
May 29, 2014 05:04 ET | Source: uniQure

uniQure and Medison Sign Glybera(R) Distribution Agreement for Israel

AMSTERDAM, The Netherlands and PETACH TIKVA, Israel, May 29, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading...
May 27, 2014 05:10 ET | Source: uniQure

uniQure Announces Successful Transfection of Liver Cells with AAV5 and Strong Safety Data from Acute Intermittent Porphyria Clinical Trial

--Phase I Interim Results of AMT-021 Presented at ASGCT Conference-- AMSTERDAM, The Netherlands, May 27, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today...
May 15, 2014 05:18 ET | Source: uniQure

uniQure to Present at the BioEquity Europe and Jefferies Global Healthcare Conferences

AMSTERDAM, The Netherlands, May 15, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the...
April 09, 2014 07:03 ET | Source: uniQure

uniQure Announces Changes in Management Team

AMSTERDAM, The Netherlands, April 9, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the appointment of Eric Goossens as its new Chief Operating...
March 26, 2014 08:12 ET | Source: uniQure

uniQure Announces Results for Financial Year 2013

AMSTERDAM, The Netherlands, March 26, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced unaudited results for the financial year ended December 31,...
March 21, 2014 11:34 ET | Source: uniQure

uniQure to Present at Future Leaders in Biotech Conference

Amsterdam, The Netherlands, March 21, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the...
March 17, 2014 06:18 ET | Source: uniQure

uniQure and Chiesi Announce Six Year Follow-up Data from Glybera(r) Treated Patients

AMSTERDAM, Netherlands, March 17, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, and Chiesi Farmaceutici S.p.A. ("Chiesi"), a leading international...